Unseen Epidemic, Millions of Indians Are Haunted by the Threat of Cancer Key Findings from the Report: - 60% of respondents reported moderate to extreme worry about developing cancer. - 33% expressed significant concerns over the financial burden of cancer treatment. - 24% feared death as a result
In a groundbreaking study led by Dr. Geetanjali Gupta, Director of Technical Operations & Quality Assurance at Redcliffe Labs, in collaboration with a global healthcare company, Redcliffe Labs has achieved remarkable results in laboratory quality metrics. The study found that approximately 75% of the analytes
The Ad Campaign aims to promote the culture of preventive breast cancer screening amongst the age group of 40-55. The story beautifully touches on the nuances of fear and hesitation to speak-up about women health issues which needs to be fought back. The 2-minute-long ad
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time. Oral semaglutide will be a gamechanger for people with type 2 diabetes who prefer oral medications over injections. was
